1. Lung cancer: how to face the revolution?

   • Jean-François Morère
   • Frédérique Penault-Llorca

   Editorial 28 February 2013 Pages: 1 - 2

2. Identification of driver mutations in lung cancer: first step in personalized cancer

   • David Planchard

   Cancer Concepts 01 February 2013 Pages: 3 - 14

3. Update on antiangiogenic treatment of advanced non-small cell lung cancer (NSCLC)

   • Gerald Schmid-Bindert

   Review 01 February 2013 Pages: 15 - 26

   

4. Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC)

   • Kunihiko Kobayashi
   • Koichi Hagiwara

   Review Open access 30 January 2013 Pages: 27 - 33

   

5. Clinical meta-analyses of targeted therapies in adenocarcinoma

   • Emilio Bria
   • Maria Bonomi
   • Giorgio Scagliotti

   Review 25 January 2013 Pages: 35 - 45

6. EGFR-directed monoclonal antibodies in non-small cell lung cancer

   • Robert Pirker

   Review 09 January 2013 Pages: 47 - 53

7. ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC

   • Francesca Casaluce
   • Assunta Sgambato
   • Cesare Gridelli

   Review 17 January 2013 Pages: 55 - 67

   

8. Other signalization targets

   • Nicolas Girard

   Review 10 January 2013 Pages: 69 - 77